Valeritas Holdings is a commercial-stage medical technology company focused on improving health for people with diabetes by developing and commercializing technologies. Co.'s product, V-Go® Wearable Insulin Delivery device, is an all-in-one basal-bolus insulin delivery option for patients with type 2 diabetes that is worn like a patch and can eliminate the need for taking multiple daily shots. Co. developed V-Go utilizing its technology, the h-Patch platform, as a patient-focused solution to address the challenges of insulin therapies. Co.'s h-Patch platform facilitates the subcutaneous delivery of injectable medicines to patients across a range of therapeutic areas.
|
Free VLRX Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |